Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I

Michael P. Busch, Patricia E. Taylor, Bruce A. Lenes, Steven H. Kleinman, Marla Stuart, Cladd E. Stevens, Peter A. Tomasulo, Jean Pierre Allain, Charles G. Hollingsworth, James W. Mosley, S. P. Azen, D. J. Bregman, M. F. Dougherty, J. Gaiennie, C. S. Johnson, C. K. Kasper, A. Kennedy, J. M. Nelson, E. A. Operskalski, J. W. ParkerD. R. Powars, M. Stuart, E. Taylor-Munoz, S. H. Kleinman, C. Hyman, S. L. Dietrich, J. M. Lusher, J. Kaplan, S. Sarnaik, E. R. Schiff, M. De Medina, M. A. Fletcher, E. C Y Lian, C. Pegelow, K. R. Reddy, J. D. Temple, S. Toledano, B. Lenes, P. A. Tomasulo, L. M. Aledort, J. Hassett, H. Sacks, P. Wiesen, M. W. Hilgartner, E. Donegan, M. A. Koerper, K. Miller, D. P. Stites, G. N. Vyas, H. A. Perkins, M. P. Busch, R. A. Johnson, B. H. Lewis, R. B. Counts, G. F. Gjerset, C. G. Hollingsworth, G. J. Nemo, J. Hoak, H. J. Alter, G. J. Grady, P. V. Holland, J. Osborne, N. R. Rose, L. B. Seeff, J. Wittes

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Background. The p24 antigen of human immunodeficiency virus type 1 (HIV-1) is sometimes detected before antibody (anti-HIV-1) is detectable in the serum of recently infected persons. This has led to the consideration of p24-antigen testing for routine screening of blood donors. Methods. To estimate how many HIV-infected seronegative donors would be identified if p24-antigen screening was introduced, we tested selected donations from a repository of 200,000 serum samples from voluntary donors that was established in late 1984 and early 1985. The 8597 serum samples selected for p24-antigen screening were chosen because their donors had demographic characteristics known to be associated with a high prevalence of seropositivity. Results. The prevalence of anti-HIV-1 antibodies in the 1984-1985 serum samples selected for p24-antigen screening was 1.54 percent - more than 100 times the 0.012 percent prevalence in present-day donations in the United States. The antigen was detected in 15 of 132 serum samples (11.4 percent) from donors who had already been confirmed as seropositive. No instance of confirmed positivity for p24 antigen was found among the 8465 seronegative serum samples. Conclusions. These data indicate that the yield of screening for p24 antigen in volunteer donors to identify HIV-1 carriers would be negligible. We therefore recommend against routine screening with currently available p24-antigen assays.

Original languageEnglish
Pages (from-to)1308-1312
Number of pages5
JournalNew England Journal of Medicine
Volume323
Issue number19
StatePublished - Nov 8 1990
Externally publishedYes

Fingerprint

Blood Donors
HIV
Antigens
Tissue Donors
HIV-1
Serum
Volunteers
Anti-Idiotypic Antibodies
Demography
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Busch, M. P., Taylor, P. E., Lenes, B. A., Kleinman, S. H., Stuart, M., Stevens, C. E., ... Wittes, J. (1990). Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I. New England Journal of Medicine, 323(19), 1308-1312.

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I. / Busch, Michael P.; Taylor, Patricia E.; Lenes, Bruce A.; Kleinman, Steven H.; Stuart, Marla; Stevens, Cladd E.; Tomasulo, Peter A.; Allain, Jean Pierre; Hollingsworth, Charles G.; Mosley, James W.; Azen, S. P.; Bregman, D. J.; Dougherty, M. F.; Gaiennie, J.; Johnson, C. S.; Kasper, C. K.; Kennedy, A.; Nelson, J. M.; Operskalski, E. A.; Parker, J. W.; Powars, D. R.; Stuart, M.; Taylor-Munoz, E.; Kleinman, S. H.; Hyman, C.; Dietrich, S. L.; Lusher, J. M.; Kaplan, J.; Sarnaik, S.; Schiff, E. R.; De Medina, M.; Fletcher, M. A.; Lian, E. C Y; Pegelow, C.; Reddy, K. R.; Temple, J. D.; Toledano, S.; Lenes, B.; Tomasulo, P. A.; Aledort, L. M.; Hassett, J.; Sacks, H.; Wiesen, P.; Hilgartner, M. W.; Donegan, E.; Koerper, M. A.; Miller, K.; Stites, D. P.; Vyas, G. N.; Perkins, H. A.; Busch, M. P.; Johnson, R. A.; Lewis, B. H.; Counts, R. B.; Gjerset, G. F.; Hollingsworth, C. G.; Nemo, G. J.; Hoak, J.; Alter, H. J.; Grady, G. J.; Holland, P. V.; Osborne, J.; Rose, N. R.; Seeff, L. B.; Wittes, J.

In: New England Journal of Medicine, Vol. 323, No. 19, 08.11.1990, p. 1308-1312.

Research output: Contribution to journalArticle

Busch, MP, Taylor, PE, Lenes, BA, Kleinman, SH, Stuart, M, Stevens, CE, Tomasulo, PA, Allain, JP, Hollingsworth, CG, Mosley, JW, Azen, SP, Bregman, DJ, Dougherty, MF, Gaiennie, J, Johnson, CS, Kasper, CK, Kennedy, A, Nelson, JM, Operskalski, EA, Parker, JW, Powars, DR, Stuart, M, Taylor-Munoz, E, Kleinman, SH, Hyman, C, Dietrich, SL, Lusher, JM, Kaplan, J, Sarnaik, S, Schiff, ER, De Medina, M, Fletcher, MA, Lian, ECY, Pegelow, C, Reddy, KR, Temple, JD, Toledano, S, Lenes, B, Tomasulo, PA, Aledort, LM, Hassett, J, Sacks, H, Wiesen, P, Hilgartner, MW, Donegan, E, Koerper, MA, Miller, K, Stites, DP, Vyas, GN, Perkins, HA, Busch, MP, Johnson, RA, Lewis, BH, Counts, RB, Gjerset, GF, Hollingsworth, CG, Nemo, GJ, Hoak, J, Alter, HJ, Grady, GJ, Holland, PV, Osborne, J, Rose, NR, Seeff, LB & Wittes, J 1990, 'Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I', New England Journal of Medicine, vol. 323, no. 19, pp. 1308-1312.
Busch MP, Taylor PE, Lenes BA, Kleinman SH, Stuart M, Stevens CE et al. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I. New England Journal of Medicine. 1990 Nov 8;323(19):1308-1312.
Busch, Michael P. ; Taylor, Patricia E. ; Lenes, Bruce A. ; Kleinman, Steven H. ; Stuart, Marla ; Stevens, Cladd E. ; Tomasulo, Peter A. ; Allain, Jean Pierre ; Hollingsworth, Charles G. ; Mosley, James W. ; Azen, S. P. ; Bregman, D. J. ; Dougherty, M. F. ; Gaiennie, J. ; Johnson, C. S. ; Kasper, C. K. ; Kennedy, A. ; Nelson, J. M. ; Operskalski, E. A. ; Parker, J. W. ; Powars, D. R. ; Stuart, M. ; Taylor-Munoz, E. ; Kleinman, S. H. ; Hyman, C. ; Dietrich, S. L. ; Lusher, J. M. ; Kaplan, J. ; Sarnaik, S. ; Schiff, E. R. ; De Medina, M. ; Fletcher, M. A. ; Lian, E. C Y ; Pegelow, C. ; Reddy, K. R. ; Temple, J. D. ; Toledano, S. ; Lenes, B. ; Tomasulo, P. A. ; Aledort, L. M. ; Hassett, J. ; Sacks, H. ; Wiesen, P. ; Hilgartner, M. W. ; Donegan, E. ; Koerper, M. A. ; Miller, K. ; Stites, D. P. ; Vyas, G. N. ; Perkins, H. A. ; Busch, M. P. ; Johnson, R. A. ; Lewis, B. H. ; Counts, R. B. ; Gjerset, G. F. ; Hollingsworth, C. G. ; Nemo, G. J. ; Hoak, J. ; Alter, H. J. ; Grady, G. J. ; Holland, P. V. ; Osborne, J. ; Rose, N. R. ; Seeff, L. B. ; Wittes, J. / Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I. In: New England Journal of Medicine. 1990 ; Vol. 323, No. 19. pp. 1308-1312.
@article{ec4c12f69a154aeaa8e75b7fd8d15072,
title = "Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I",
abstract = "Background. The p24 antigen of human immunodeficiency virus type 1 (HIV-1) is sometimes detected before antibody (anti-HIV-1) is detectable in the serum of recently infected persons. This has led to the consideration of p24-antigen testing for routine screening of blood donors. Methods. To estimate how many HIV-infected seronegative donors would be identified if p24-antigen screening was introduced, we tested selected donations from a repository of 200,000 serum samples from voluntary donors that was established in late 1984 and early 1985. The 8597 serum samples selected for p24-antigen screening were chosen because their donors had demographic characteristics known to be associated with a high prevalence of seropositivity. Results. The prevalence of anti-HIV-1 antibodies in the 1984-1985 serum samples selected for p24-antigen screening was 1.54 percent - more than 100 times the 0.012 percent prevalence in present-day donations in the United States. The antigen was detected in 15 of 132 serum samples (11.4 percent) from donors who had already been confirmed as seropositive. No instance of confirmed positivity for p24 antigen was found among the 8465 seronegative serum samples. Conclusions. These data indicate that the yield of screening for p24 antigen in volunteer donors to identify HIV-1 carriers would be negligible. We therefore recommend against routine screening with currently available p24-antigen assays.",
author = "Busch, {Michael P.} and Taylor, {Patricia E.} and Lenes, {Bruce A.} and Kleinman, {Steven H.} and Marla Stuart and Stevens, {Cladd E.} and Tomasulo, {Peter A.} and Allain, {Jean Pierre} and Hollingsworth, {Charles G.} and Mosley, {James W.} and Azen, {S. P.} and Bregman, {D. J.} and Dougherty, {M. F.} and J. Gaiennie and Johnson, {C. S.} and Kasper, {C. K.} and A. Kennedy and Nelson, {J. M.} and Operskalski, {E. A.} and Parker, {J. W.} and Powars, {D. R.} and M. Stuart and E. Taylor-Munoz and Kleinman, {S. H.} and C. Hyman and Dietrich, {S. L.} and Lusher, {J. M.} and J. Kaplan and S. Sarnaik and Schiff, {E. R.} and {De Medina}, M. and Fletcher, {M. A.} and Lian, {E. C Y} and C. Pegelow and Reddy, {K. R.} and Temple, {J. D.} and S. Toledano and B. Lenes and Tomasulo, {P. A.} and Aledort, {L. M.} and J. Hassett and H. Sacks and P. Wiesen and Hilgartner, {M. W.} and E. Donegan and Koerper, {M. A.} and K. Miller and Stites, {D. P.} and Vyas, {G. N.} and Perkins, {H. A.} and Busch, {M. P.} and Johnson, {R. A.} and Lewis, {B. H.} and Counts, {R. B.} and Gjerset, {G. F.} and Hollingsworth, {C. G.} and Nemo, {G. J.} and J. Hoak and Alter, {H. J.} and Grady, {G. J.} and Holland, {P. V.} and J. Osborne and Rose, {N. R.} and Seeff, {L. B.} and J. Wittes",
year = "1990",
month = "11",
day = "8",
language = "English",
volume = "323",
pages = "1308--1312",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "19",

}

TY - JOUR

T1 - Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I

AU - Busch, Michael P.

AU - Taylor, Patricia E.

AU - Lenes, Bruce A.

AU - Kleinman, Steven H.

AU - Stuart, Marla

AU - Stevens, Cladd E.

AU - Tomasulo, Peter A.

AU - Allain, Jean Pierre

AU - Hollingsworth, Charles G.

AU - Mosley, James W.

AU - Azen, S. P.

AU - Bregman, D. J.

AU - Dougherty, M. F.

AU - Gaiennie, J.

AU - Johnson, C. S.

AU - Kasper, C. K.

AU - Kennedy, A.

AU - Nelson, J. M.

AU - Operskalski, E. A.

AU - Parker, J. W.

AU - Powars, D. R.

AU - Stuart, M.

AU - Taylor-Munoz, E.

AU - Kleinman, S. H.

AU - Hyman, C.

AU - Dietrich, S. L.

AU - Lusher, J. M.

AU - Kaplan, J.

AU - Sarnaik, S.

AU - Schiff, E. R.

AU - De Medina, M.

AU - Fletcher, M. A.

AU - Lian, E. C Y

AU - Pegelow, C.

AU - Reddy, K. R.

AU - Temple, J. D.

AU - Toledano, S.

AU - Lenes, B.

AU - Tomasulo, P. A.

AU - Aledort, L. M.

AU - Hassett, J.

AU - Sacks, H.

AU - Wiesen, P.

AU - Hilgartner, M. W.

AU - Donegan, E.

AU - Koerper, M. A.

AU - Miller, K.

AU - Stites, D. P.

AU - Vyas, G. N.

AU - Perkins, H. A.

AU - Busch, M. P.

AU - Johnson, R. A.

AU - Lewis, B. H.

AU - Counts, R. B.

AU - Gjerset, G. F.

AU - Hollingsworth, C. G.

AU - Nemo, G. J.

AU - Hoak, J.

AU - Alter, H. J.

AU - Grady, G. J.

AU - Holland, P. V.

AU - Osborne, J.

AU - Rose, N. R.

AU - Seeff, L. B.

AU - Wittes, J.

PY - 1990/11/8

Y1 - 1990/11/8

N2 - Background. The p24 antigen of human immunodeficiency virus type 1 (HIV-1) is sometimes detected before antibody (anti-HIV-1) is detectable in the serum of recently infected persons. This has led to the consideration of p24-antigen testing for routine screening of blood donors. Methods. To estimate how many HIV-infected seronegative donors would be identified if p24-antigen screening was introduced, we tested selected donations from a repository of 200,000 serum samples from voluntary donors that was established in late 1984 and early 1985. The 8597 serum samples selected for p24-antigen screening were chosen because their donors had demographic characteristics known to be associated with a high prevalence of seropositivity. Results. The prevalence of anti-HIV-1 antibodies in the 1984-1985 serum samples selected for p24-antigen screening was 1.54 percent - more than 100 times the 0.012 percent prevalence in present-day donations in the United States. The antigen was detected in 15 of 132 serum samples (11.4 percent) from donors who had already been confirmed as seropositive. No instance of confirmed positivity for p24 antigen was found among the 8465 seronegative serum samples. Conclusions. These data indicate that the yield of screening for p24 antigen in volunteer donors to identify HIV-1 carriers would be negligible. We therefore recommend against routine screening with currently available p24-antigen assays.

AB - Background. The p24 antigen of human immunodeficiency virus type 1 (HIV-1) is sometimes detected before antibody (anti-HIV-1) is detectable in the serum of recently infected persons. This has led to the consideration of p24-antigen testing for routine screening of blood donors. Methods. To estimate how many HIV-infected seronegative donors would be identified if p24-antigen screening was introduced, we tested selected donations from a repository of 200,000 serum samples from voluntary donors that was established in late 1984 and early 1985. The 8597 serum samples selected for p24-antigen screening were chosen because their donors had demographic characteristics known to be associated with a high prevalence of seropositivity. Results. The prevalence of anti-HIV-1 antibodies in the 1984-1985 serum samples selected for p24-antigen screening was 1.54 percent - more than 100 times the 0.012 percent prevalence in present-day donations in the United States. The antigen was detected in 15 of 132 serum samples (11.4 percent) from donors who had already been confirmed as seropositive. No instance of confirmed positivity for p24 antigen was found among the 8465 seronegative serum samples. Conclusions. These data indicate that the yield of screening for p24 antigen in volunteer donors to identify HIV-1 carriers would be negligible. We therefore recommend against routine screening with currently available p24-antigen assays.

UR - http://www.scopus.com/inward/record.url?scp=0025075451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025075451&partnerID=8YFLogxK

M3 - Article

C2 - 2120588

AN - SCOPUS:0025075451

VL - 323

SP - 1308

EP - 1312

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 19

ER -